Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Vehreschild

Showing results (201-210 of 221) with videos related to

Pageof 23
Sort By:
American Journal of Physiology. Cell Physiology|June 5, 2023
Pathogenetic mechanisms and therapeutic approaches of acute-to-chronic liver failureRobert Schierwagen, Wenyi Gu, Angela Brieger, et al.
Brain, Behavior, & Immunity - Health|June 8, 2026
An externally validated machine learning algorithm for predicting mental and physical health outcomes three months post-hospitalization for severe viral infection with SARS-CoV-2Katharina Schultebraucks, Sapir Gershov, Felix Fischer, et al.
Biomedicines|October 27, 2022
COVID-19 Severity and Thrombo-Inflammatory Response Linked to EthnicityBeate Heissig, Yousef Salama, Roman Iakoubov, et al.
Frontiers in Medicine|March 21, 2024
The protective effect of tumor necrosis factor-alpha inhibitors in COVID-19 in patients with inflammatory rheumatic diseases compared to the general population-A comparison of two German registriesRebecca Hasseli, Frank Hanses, Melanie Stecher, et al.
The Journal of Hospital Infection|February 22, 2026
All-cause mortality and risk factors for death in patients with Clostridioides difficile infections: a prospective multicentre cohort study in six German university hospitals, 2016-2020Anna M Rohde, Winfried V Kern, Michael Behnke, et al.
Nature Immunology|February 16, 2023
Pyrimidine de novo synthesis inhibition selectively blocks effector but not memory T cell developmentStefanie Scherer, Susanne G Oberle, Kristiyan Kanev, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 25, 2021
Severe Dysbiosis and Specific Haemophilus and Neisseria Signatures as Hallmarks of the Oropharyngeal Microbiome in Critically Ill Coronavirus Disease 2019 (COVID-19) PatientsJuliana de Castilhos, Eli Zamir, Theresa Hippchen, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|October 15, 2013
Improvement in the outcome of invasive fusariosis in the last decadeM Nucci, K A Marr, M J G T Vehreschild, et al.
Infection|May 3, 2024
Comparison of post-COVID-19 symptoms in patients infected with the SARS-CoV-2 variants delta and omicron-results of the Cross-Sectoral Platform of the German National Pandemic Cohort Network (NAPKON-SUEP)Sina M Hopff, Katharina S Appel, Olga Miljukov, et al.
Scientific Reports|June 13, 2024
A precise performance-based reimbursement model for the multi-centre NAPKON cohorts - development and evaluationKatharina S Appel, Chin Huang Lee, Susana M Nunes de Miranda, et al.
Pageof 23

Showing results (201-210 of 221) with videos related to

Sort By:
Pageof 23
American Journal of Physiology. Cell Physiology|June 5, 2023
Pathogenetic mechanisms and therapeutic approaches of acute-to-chronic liver failureRobert Schierwagen, Wenyi Gu, Angela Brieger, et al.
Brain, Behavior, & Immunity - Health|June 8, 2026
An externally validated machine learning algorithm for predicting mental and physical health outcomes three months post-hospitalization for severe viral infection with SARS-CoV-2Katharina Schultebraucks, Sapir Gershov, Felix Fischer, et al.
Biomedicines|October 27, 2022
COVID-19 Severity and Thrombo-Inflammatory Response Linked to EthnicityBeate Heissig, Yousef Salama, Roman Iakoubov, et al.
Frontiers in Medicine|March 21, 2024
The protective effect of tumor necrosis factor-alpha inhibitors in COVID-19 in patients with inflammatory rheumatic diseases compared to the general population-A comparison of two German registriesRebecca Hasseli, Frank Hanses, Melanie Stecher, et al.
The Journal of Hospital Infection|February 22, 2026
All-cause mortality and risk factors for death in patients with Clostridioides difficile infections: a prospective multicentre cohort study in six German university hospitals, 2016-2020Anna M Rohde, Winfried V Kern, Michael Behnke, et al.
Nature Immunology|February 16, 2023
Pyrimidine de novo synthesis inhibition selectively blocks effector but not memory T cell developmentStefanie Scherer, Susanne G Oberle, Kristiyan Kanev, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 25, 2021
Severe Dysbiosis and Specific Haemophilus and Neisseria Signatures as Hallmarks of the Oropharyngeal Microbiome in Critically Ill Coronavirus Disease 2019 (COVID-19) PatientsJuliana de Castilhos, Eli Zamir, Theresa Hippchen, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|October 15, 2013
Improvement in the outcome of invasive fusariosis in the last decadeM Nucci, K A Marr, M J G T Vehreschild, et al.
Infection|May 3, 2024
Comparison of post-COVID-19 symptoms in patients infected with the SARS-CoV-2 variants delta and omicron-results of the Cross-Sectoral Platform of the German National Pandemic Cohort Network (NAPKON-SUEP)Sina M Hopff, Katharina S Appel, Olga Miljukov, et al.
Scientific Reports|June 13, 2024
A precise performance-based reimbursement model for the multi-centre NAPKON cohorts - development and evaluationKatharina S Appel, Chin Huang Lee, Susana M Nunes de Miranda, et al.
Pageof 23